Evidence map›Paper›PMID 40266411›Full record

ArticleMolecular biomedicine2025

Structural and functional insights into metal coordination and substrate recognition of Akkermansia muciniphila sialidase Amuc_1547.

Tao Li, XinYue Tang, YiBo Zhu, NingLin Zhao, YingJie Song, Lihui He, XingYu Mou, Chunlei Ge, Zhenpu Chen, Hai Zhang and 5 more

Abstract read
In one paragraph

Article in Molecular biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tao Li *Cancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
XinYue Tang *Center of Infectious Diseases, Division of Infectious Diseases in State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
YiBo Zhu *Accurate Biotechnology (Hunan) Co, Ltd, Changsha, 410006, China.
NingLin ZhaoCenter of Infectious Diseases, Division of Infectious Diseases in State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
YingJie SongCollege of Life Science, Sichuan Normal University, Chengdu, 610101, China.
Lihui HeDepartment of Pharmacy, Chengdu Second People's Hospital, Chengdu, China.
XingYu MouCenter of Infectious Diseases, Division of Infectious Diseases in State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Chunlei GeCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Zhenpu ChenCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Hai ZhangCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Xiaoxuan YaoCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Xiaoyuan HuCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Jiaxing ChengCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Hong YaoCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Rui BaoCenter of Infectious Diseases, Division of Infectious Diseases in State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. baorui@scu.edu.cn.ORCID http://orcid.org/0000-0002-6083-8716

Funding

First-Class Discipline Team of Kunming Medical University 2024XKTDYS07Joint Special Funds for the Department of Science and Technology of Yunnan Province‑Kunming Medical University 202401AY070001-360National Natural Science Foundation of China 32360046National Natural Science Foundation of China 32370187National Natural Science Foundation of China 82260462National Natural Science Foundation of China 82350117, 82160476the Postdoctoral Science Foundation of China GZC20241164Yunnan Fundamental Research Projects 202301AT070129Yunnan Provincial Department of Education Science Research Fund Project 2023Y0655
6 · The paper itself

Abstract

Sialidases in Akkermansia muciniphila are pivotal for mucin degradation, enabling energy acquisition, modulating gut microbiota balance, and influencing host health. However, their structural and functional mechanisms remain poorly characterized. This study resolved the magnesium-bound crystal structure of Amuc_1547, revealing a six-bladed β-propeller fold linked to a carbohydrate-binding module (CBM)-like β-sandwich domain. Structural characterization ​identified a conserved S-x-D-x-G-x-x-W motif, a unique metal-binding pocket coordinated by residues Glu289, Glu299, and Asp300, and a putative carbohydrate substrate-binding pocket within the CBM-like domain. Enzymatic assays confirmed the functional relevance of these structural elements and demonstrated that both metal ions and glycans significantly enhance enzymatic activity. Molecular docking, dynamics simulations, and enzyme kinetics analysis identified critical residue substitutions involved in sialic acid substrate binding and catalysis: Gln367 replaces an arginine in the classical Arg-triplet, while Gln350 and His349 ​replace the nucleophilic tyrosine. These substitutions collectively mediate substrate binding, nucleophilic attack, and transition state stabilization, distinguishing the catalytic mechanism of Amuc_1547 from other six-bladed β-propeller sialidases. Additionally, comparative analysis of the four A. muciniphila sialidases highlights sequence divergence and domain architecture variations, suggesting niche-specific roles in gut microenvironments. Our work not only deciphers the structural basis of metal-dependent substrate recognition in Amuc_1547 but also advances our understanding of the adaptation of A. muciniphila to gut niches, offering a blueprint for leveraging sialidase-driven mucin metabolism in microbiota-targeted therapies.

Indexed as

Bacterial ProteinsMetalsNeuraminidaseAkkermansiaAmino Acid SequenceBinding SitesCrystallography, X-RayKineticsMolecular Docking SimulationMolecular Dynamics SimulationProtein BindingSubstrate SpecificityBacterial ProteinsMetalsNeuraminidaseA. muciniphilaCBM-like domainCrystal structureSialidaseSix-blade β-propeller

Identifiers

PMID40266411
PMCPMC12018670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.